TAM
PFE icon

Titleist Asset Management’s Pfizer PFE Stock Holding History

Titleist Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9,513
Closed -$241K – 330
2025
Q1 		$241K Sell
9,513
-1,399
-13% -$36.6K 0.03% 267
2024
Q4 		$289K Sell
10,912
-4,502
-29% -$122K 0.03% 254
2024
Q3 		$446K Sell
15,414
-981
-6% -$28.6K 0.06% 182
2024
Q2 		$459K Buy
16,395
+1,567
+11% +$43.1K 0.07% 176
2024
Q1 		$411K Buy
14,828
+1,546
+12% +$42.9K 0.07% 176
2023
Q4 		$382K Buy
+13,282
New +$402K 0.07% 163

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Titleist Asset Management's PFE Position: Q2 2025 in Review

Titleist Asset Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 9,513 shares — an estimated $241K sold.

Titleist Asset Management first reported a position in PFE in Q4 2023 and held it in 6 quarters. The position peaked at $459K in Q2 2024. 2,810 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Titleist Asset Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Titleist Asset Management sold 9,513 Pfizer shares in Q2 2025, an estimated $241K.
  • Titleist Asset Management first reported a position in Pfizer in Q4 2023 and held it in 6 quarters.
  • Titleist Asset Management's Pfizer position peaked at $459K in Q2 2024.
  • 2,810 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Titleist Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.